A prostate cancer therapy that greatly reduces the time required for treatment has become available for the first time in regional NSW.
Matthew Hoffmann, acting manager of radiotherapy at the Mid North Coast Cancer Institute (MNCCI) in Coffs Harbour, said stereotactic radiotherapy delivered higher, more precise treatment doses.